Hadassah Medical Center
Jerusalem's university hospital and Sharett Institute of Oncology, known for in-house CAR-T, BRCA founder mutation research and melanoma immunotherapy.
Hadassah Medical Center's Ein Kerem and Mount Scopus campuses house the Sharett Institute of Oncology and the Hebrew University's medical faculty. Polina Stepensky's bone marrow transplantation and immunotherapy department manufactures its own CD19 and BCMA CAR-T products, making Hadassah one of the first hospitals worldwide to deliver academic point-of-care CAR-T at scale; Michal Lotem's melanoma unit has long run tumour vaccine and immunotherapy trials, Tamar Peretz's oncogenetics group characterised BRCA founder mutations in Ashkenazi Jewish populations, and Aron Popovtzer leads head and neck oncology. The centre provides radiotherapy, gamma knife, paediatric haemato-oncology and a phase 1 unit for Jerusalem and the surrounding region.
- Point-of-care CAR-T
- Oncogenetics and BRCA
- Melanoma immunotherapy
- Head and neck oncology
- Paediatric haemato-oncology
Pages like this
not linked directly; found by shared links- IdeaHospital-made CAR-T under one shared regulatory master file
Shares BCMA, CD19, Manufacturing cost and time for living and radioactive medicines, Multiple myeloma.
- IdeaPlan the second CAR-T target before the first one is lost
Shares BCMA, CD19, Manufacturing cost and time for living and radioactive medicines, Multiple myeloma.
- IdeaHospital-based CAR-T manufacturing at cost through a public network
Shares BCMA, CD19, Manufacturing cost and time for living and radioactive medicines, Multiple myeloma.
- IdeaNon-profit, open-licence lentiviral vectors and producer cell lines for CAR-T
Shares BCMA, CD19, Manufacturing cost and time for living and radioactive medicines, CAR-T cell therapy.
- InstitutionUnion Hospital, Tongji Medical College
Shares BCMA, CD19, Multiple myeloma, Diffuse large B-cell lymphoma.
- InstitutionHospital Clínic de Barcelona / IDIBAPS
Shares BCMA, CD19, Manufacturing cost and time for living and radioactive medicines, Multiple myeloma.
- IdeaCollect and freeze T cells at diagnosis for high-risk patients, before chemotherapy
Shares Manufacturing cost and time for living and radioactive medicines, Multiple myeloma, Diffuse large B-cell lymphoma, CAR-T cell therapy.
- IdeaIn vivo CAR-T manufactured and priced like a generic biologic
Shares BCMA, CD19, Manufacturing cost and time for living and radioactive medicines, Multiple myeloma.